Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 13613 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 13952 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 14383 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 15404 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 15565 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 15746 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 16871 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 17019 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 17070 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 17207 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 18045 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 18053 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 18053 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 19435 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 20425 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 20438 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 20515 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 20707 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 20764 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 21020 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 21575 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 23297 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 24580 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 28691 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 30823 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 39531 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 3602 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 3779 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 4304 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 4711 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 4742 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 4781 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 4810 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 5197 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 5204 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 5229 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 5370 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 5430 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 5785 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 5991 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 6131 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 6316 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 6515 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 6662 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 6755 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 6785 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 6871 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 7128 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 7494 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 7818 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | 8128 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+NA)+ | Peak area normalized | female | Pre-diabetic | Neuropathy |